Low-dose modified-release prednisone in axial spondyloarthritis: 3-month efficacy and tolerability.
about
Low-dose modified-release prednisone in axial spondyloarthritis: 3-month efficacy and tolerability.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
Low-dose modified-release pred ...... nth efficacy and tolerability.
@en
Low-dose modified-release pred ...... nth efficacy and tolerability.
@nl
type
label
Low-dose modified-release pred ...... nth efficacy and tolerability.
@en
Low-dose modified-release pred ...... nth efficacy and tolerability.
@nl
prefLabel
Low-dose modified-release pred ...... nth efficacy and tolerability.
@en
Low-dose modified-release pred ...... nth efficacy and tolerability.
@nl
P2093
P2860
P356
P1476
Low-dose modified-release pred ...... nth efficacy and tolerability.
@en
P2093
Claudio Marcassa
Emanuela Pimenta da Fonseca
Francesca Bandinelli
Francesca Nacci
Francesco Scazzariello
Mittermayer Barreto Santiago
P2860
P304
P356
10.2147/DDDT.S115099
P407
P577
2016-11-14T00:00:00Z